Jersey City, NJ, United States of America

Alexandre Gross

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 69(Granted Patents)

Company Filing History:

Aventis Pharmaceuticals Inc.

patents

4. 1 out of 44

Celgene Avilomics Research, Inc.

patents

where one patent can have more than one assignee

Years Active: 2007-2020

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10774052 - Heteroaryl compounds and uses thereof (2020-09-15),

2. 10618902 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases (2020-04-14),

3. 10189794 - Heteroaryl compounds and uses thereof (2019-01-29),

4. 10065966 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases (2018-09-04),

5. 9695132 - Heteroaryl compounds and uses thereof (2017-07-04),

6. 9663524 - Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors (2017-05-30),

7. 9321786 - Heteroaryl compounds and uses thereof (2016-04-26),

8. 7741493 - Heterocyclic compounds as P2X7 ion channel blockers (2010-06-22),

9. 7541368 - Pyrazoles as inhibitors of tumor necrosis factor (2009-06-02),

10. 7326792 - Heterocyclic compounds as P2X7 ion channel blockers (2008-02-05),

11. 7169925 - Indole derivatives as interleukin-4 gene expression inhibitors (2007-01-30),

Title: The Innovative Journey of Alexandre Gross: Pioneering Inventor From Jersey City, NJ

Introduction:

Alexandre Gross, a visionary inventor hailing from Jersey City, NJ, has made significant contributions to the field of pharmaceuticals with a total of 11 patents to his name. His relentless pursuit of innovation has led to groundbreaking discoveries that have the potential to revolutionize the healthcare industry.

Latest Patents:

Among his latest patents is the groundbreaking invention of Heteroaryl compounds and their versatile uses in pharmaceutical compositions. Additionally, Alexandre Gross has patented Substituted pyrido[2,3-d]pyrimidines as potent inhibitors of protein kinases, showcasing his expertise in developing novel therapeutic agents.

Career Highlights:

Throughout his career, Alexandre Gross has lent his inventive prowess to prestigious companies such as Sanofi and Celgene Car LLC. His tenure at these organizations has been marked by a string of successful patent filings, cementing his reputation as a trailblazer in the pharmaceutical realm.

Collaborations:

Collaborating with esteemed colleagues has been instrumental in Alexandre Gross's prolific career. Notable collaborators include Laura Akullian D'Agostino and Robert Tjin Tham Sjin, individuals who have shared his passion for innovation and pushed the boundaries of scientific discovery alongside him.

Conclusion:

In conclusion, Alexandre Gross stands as a beacon of innovation in the field of pharmaceuticals, with a track record of patents that exemplify his dedication to advancing healthcare solutions. His profound impact on the industry serves as a testament to the transformative power of visionary inventors like him.

This text is generated by artificial intelligence and may not be accurate.